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ABSTRACT
The emergence of multiresistant Gram-negative bacteria requires new therapies for combating
bacterial infections. Targeting the biogenesis of virulence factors could be an alternative
strategy instead of killing bacteria with antibiotics. The outer membrane (OM) of Gram-negative
bacteria acts as a physical barrier. At the same time it facilitates the exchange of molecules and
harbors a multitude of proteins associated with virulence. In order to insert proteins into the
OM, an essential oligomeric membrane-associated protein complex, the ß-barrel assembly
machinery (BAM) is required. Being essential for the biogenesis of outer membrane proteins
(OMPs) the BAM and also periplasmic chaperones may serve as attractive targets to develop
novel antiinfective agents. Herein, we aimed to elucidate which proteins belonging to the OMP
biogenesis machinery have the most important function in granting bacterial ﬁtness, OM barrier
function, facilitating biogenesis of dedicated virulence factors and determination of overall
virulence. To this end we used the enteropathogen Yersinia enterocolitica as a model system.
We individually knocked out all non-essential components of the BAM (BamB, C and E) as well
as the periplasmic chaperones DegP, SurA and Skp. In summary, we found that the most
profound phenotypes were produced by the loss of BamB or SurA with both knockouts
resulting in signiﬁcant attenuation or even avirulence of Ye in a mouse infection model. Thus,
we assume that both BamB and SurA are promising targets for the development of new
antiinfective drugs in the future.
KEYWORDS
antivirulence drugs; cell
surface molecules;
membrane barrier function;
outer membrane protein
biogenesis; outers
Introduction
The use of traditional antibiotics that target essential
processes in bacteria (e.g. DNA or RNA synthesis, pro-
tein synthesis, cell division) has the great disadvantage to
select for resistant subpopulations and thereby promotes
the emergence of drug resistant bacteria.1,2 The spread of
these resistances profoundly limits the treatment options
for many bacterial infections and has become a serious
global health problem. More recently, particularly Gram-
negative bacteria, e.g. carbapenem-resistant or enhanced
spectrum b-lactamase producing Enterobacteriaceae
(ESBLs) have become a great problem especially in hos-
pital settings.3,4,5 We urgently need to develop alternative
strategies to combat Gram-negative bacterial infections.
One attractive approach is to control pathogens without
killing them in ﬁrst place while preserving the endoge-
nous microbiota that is usually severely affected by anti-
biotic treatment.1,6,7 This could be achieved by drugs
that interfere with the pathogens virulence mechanisms
but do not kill them directly (e.g. by blocking adhesion
to host cells or by rendering bacteria more susceptible to
killing by the host immune system). The development of
drugs directed against Gram-negative bacteria is a great
challenge due to the OM, which prevents substances
from entering the cell because of its barrier function.2
One approach is to deﬁne targets that are in close prox-
imity to the OM or reside in the periplasm. Since a lot of
functions of the OM of Gram-negative bacteria are
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related to OMPs and particularly virulence associated
proteins are often OMPs8,9 it seems worthwile to investi-
gate if non-essential factors of the OMP biogenesis path-
way might provide potential targets for the development
of new antiinfective drugs. Additionally, drugs that are
able to induce global rearrangements of the OM that
lead to a disruption of the OM barrier function could be
exploited as sensitizers administered along with classical
antibiotics.
The OM of Gram-negative bacteria is an asymmetrical
lipid bilayer. The inner leaﬂet consists of phospholipids
whereas the outer leaﬂet consists mainly of lipopolysac-
charides (LPS).10 OMPs are synthesized in the cytoplasm
with an N-terminal signal sequence. These precursors are
then translocated across the inner membrane via the Sec-
machinery having their signal sequence cleaved off to
reach the periplasm.11 There, periplasmic chaperones like
SurA or Skp bind to the nascent OMPs to keep them in a
protected, unfolded state and guide them to the OM.12
Another chaperone, DegP, functions primarily as a prote-
ase to degrade misfolded and aggregated OMPs.13 There
exist two pathways of chaperoning OMPs across the peri-
plasm: (I) the SurA pathway and (II) the Skp/DegP path-
way.12 Although most OMPs seem to prefer the SurA
pathway, they can use Skp/DegP as a rescue pathway
under stress conditions.12,14 Actually, it has been shown
that a distinct subset of proteins that are strongly inter-
twined with the pathogenic potential of bacteria strictly
relies on the interaction with SurA in order to be inserted
properly into the OM.15,16,17 For folding and insertion of
ß-barrel proteins into the OM the BAM complex is essen-
tial.18 In E. coli this multiprotein complex is composed of
ﬁve proteins: the two essential components BamA and
BamD and the three non-essential components BamB,
BamC and BamE.18,19 BamA is the central component of
the BAM complex.18 The N-terminal periplasmic part of
BamA consists of ﬁve polypeptide transport-associated
(POTRA) domains.20 The POTRA-domains enable BamA
to interact directly or indirectly with the other compo-
nents of the BAM complex, its substrates (i.e. nascent
OMPs) and periplasmic chaperones like SurA.12,21,22
BamB has been suggested to increase the efﬁciency of
OMP biogenesis by providing a scaffold during ß-barrel
folding of nascent OMPs at the BAM complex.23 The
BamC/D/E subcomplex has been proposed to regulate the
function of the BAM complex by driving conformational
changes of BamA which enable the insertion of ß-barrel
proteins into the OM.24,25 Even though the general path-
way for OMP biogenesis from the bacterial cytoplasm to
the BAM complex has already been addressed,26 it is still
unknown how OMPs are inserted into the OM exactly
and how they adopt their ﬁnal conformation. Neverthe-
less, the recently described crystal structure of the entire
BAM complex of E. coli24 will allow us to experimentally
address concrete hypotheses that may explain the mecha-
nisms underlying OMP biogenesis in the future.
Yersinia enterocolitica (Ye) is an enteropathogenic
Gram-negative bacterium that belongs to the family of
Enterobacteriaceae. This human pathogenic bacterium
can be transmitted on oral-fecal route, usually by the
uptake of water and food contaminated with excrements
of infected pigs or other animals.27 In the small bowel,
Ye adheres to and invades epithelial cells28 leading to
mostly self-limiting enterocolitis with diarrhea, fever and
occasionally to mesenterial lymphadenitis and secondary
diseases like erythema nodosum and arthritis. In some
cases, the infection can lead to life-threatening diseases
like septicemia.27,29 In the established infection model of
murine yersiniosis it has been observed that Ye causes
similar diseases compared to humans.30 Thus this model
is perfectly suited to address all questions concerning the
contribution of distinct factors of the OMP biogenesis
machinery to virulence. The virulence of Ye is deter-
mined by several virulence factors, the most important
ones being the Yersinia adhesin A (YadA),31,32 the adhe-
sin Invasin (Inv)33 and a type III secretion system.34,35
YadA and Inv mediate binding to host cells via extracel-
lular matrix proteins and/or ß1-integrins.36,37,38 Besides
facilitating attachment to host cells, YadA also mediates
serum resistance, an important virulence trait. Serum
resistance is achieved by the interaction with various
negative regulators of the complement cascade, namely
factor H, C3b and iC3b39,40,41,42 and vitronectin.43
Our research aims at the identiﬁcation of new targets
worthwhile to be addressed in the development of new
antiinfective drugs directed against Gram-negative patho-
gens. We therefore addressed the role of the non-essential
components of the OMP biogenesis machinery (BamB, C,
E, DegP, Skp, SurA) for virulence associated phenotypes
and overall virulence. To this end we used the model
organism Ye, generated single gene knockouts, phenotypi-
cally characterized the resulting strains and ﬁnally tested
their virulence in a mouse model of infection.
Materials and methods
Bacterial strains and growth conditions
Bacteria used in this study are listed in Table S1. Ye strains
were routinely grown at 27C in lysogeny broth (LB) con-
taining suitable antibiotics overnight with shaking. Antibiot-
ics were added at the following concentrations: nalidixic acid
10 mg/ml, kanamycin 25 mg/ml, spectinomycin (Sp)
100 mg/ml, chloramphenicol (Cm) 25 mg/ ml and tetracy-
clin (Tet) 6 mg/ml. Overnight cultures were diluted into
fresh medium to an OD600 of 0,1. To generate growth
VIRULENCE 1171
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 H
els
ink
i] 
at 
02
:45
 29
 D
ec
em
be
r 2
01
7 
curves, bacteria were grown in 50ml LBmediumwith shak-
ing and growth was recorded by measuring the OD at
600 nm every 30 min over 9 h at 37C, respectively. Expres-
sion of bamB from pASK-IBA4C was induced using anhy-
drotetracyclin (AHTC) in a ﬁnal concentration of 200 ng/
ml in overnight culture and subculture.
Generation of knockout strains
The knockout strains, that are listed in Table S1 were gener-
ated using the suicide plasmid pSB890Y (a derivative of
pSB89046 where internal PstI restriction sites were
removed). The sequences of primers used are listed in
Table S2. First, pSB890Y was linearized by PCR using the
primers gib_uni_890_r2 and gib_uni_890_f2. Also the
ﬂanking regions »1000 bp up- and downstream of the tar-
get genes were ampliﬁed by PCR using the primer pairs
listed in the category “Generation of deletion mutants” in
Table S2. The vector pSB890Y and the ﬂanking regions
were then assembled using a selfmade Gibson Assembly
Master Mix47 containing T5 Exonuclease (10U ml, Epi-
centre), Phusion Polymerase (2U ml, New England Biolabs)
and Taq-DNA-Ligase (40U ml, New England Biolabs).
Next, the strain E. coli 118λpir was transformed with the
resulting plasmid. TetR clones (indicative for the presence of
pSB890Y) were selected and the presence of the inserts com-
prising the up- and downstream regions of the target genes
was veriﬁed by PCR with primers pSB890_seq_f and
pSB890_seq_r. The plasmid was then isolated using the peq-
Gold plasmid miniprep kitI (VWR) and transformed into
the diaminopimelic acid auxotroph strain E. coli ß2163.
Finally, the plasmid was transferred into the Ye wildtype
strain via mating, which resulted in TetR merodiploid Ye.
After growth at 27C without antibiotics for 24 h, Ye were
counterselected on sucrose for loss of pSB890Y. pSB890Y
encodes for a Levansucrase (sacB) that produces a toxic
metabolite if grown on sucrose. Only if the plasmid was lost
due to a second recombination event, Ye could grow on
sucrose-containing media. The knockout of target genes
was veriﬁed by PCR using the primer pairs listed in the cate-
gory “Veriﬁcation of deletions (genomicDNA)” in Table S2.
Generation of complementation constructs
For complementation of the bamB, surA and skpmutant,
the coding sequences were ampliﬁed by PCR from geno-
mic DNA of Ye wildtype strain and were assembled with
the vector pACYC or pASK-IBA4C for inducible expres-
sion (bamB complementation) using Gibson Assembly
Master Mix. Primer pairs used for the generation of the
different pACYC constructs are listed under the category
“Cloning of expression vectors for complementation of
deletions” in Table S2.
Antibiotic sensitivity
Sensitivity of the different mutant strains to rifampicin,
erythromycin, vancomycin and bacitracin was measured
by a disk diffusion assay using 6 mm ﬁlter paper-disks
(BD) after growth at 27C for 20 h, as described previ-
ously.48 Three independent experiments were carried out
for each strain.
Sensitivity against bile salts/ SDS
Sensitivity against bile salts or SDS was assessed by the
ability to grow on Mac Conkey agar (1.5 mg/ml bile
salts) or LB agar containing 0.0125 % SDS by plating a
dilution series and determining the presence of bacterial
growth after 24 h at 27C.
Preparation of OM fractions
For preparation of anOMprotein fraction 50ml of bacterial
culture grown at 37C for 4 hwithmatched numbers of bac-
terial cells were used. Cells were harvested and resuspended
in 500 ml resuspension buffer (0.2 M Tris, 1 M sucrose,
1 mM EDTA, pH 8). Then 500 mg lysozyme (20 units mg;
MSB) and 3.2 ml water were added and the samples were
incubated for 20 min at room temperature. After the addi-
tion of lysis buffer (2% Triton X-100, 50 mM Tris, 10 mM
MgCl2, pH 8) protoplasts were lysed. Released DNA was
digested with 50 mg DNaseI (10 mg/ml, Roche Applied Sci-
ence). OMs were pelleted by centrifugation at 77.100 £ g
for 45min at 4C. Resulting pellet was washed in buffer con-
taining 50 mM Tris-HCl pH8, 2% (w/v) Triton-X-100 and
10 mMMgCl2, centrifuged at 85.000£ g for 15 min at 4C.
After three washing steps with water, the membranes were
resuspended in SDS sample buffer. The OM proteins in the
samples were visualized by staining SDS gels with Coomas-
sie Brilliant Blue (Bio-Rad) for 1 h followed by destaining.
For recording of images the Odyssey imaging system (Li-
Cor Biosciences) was used.
Western blot analysis
For analysis of whole cell lysates, samples were taken
after subculturing for 4 h at 27C (analysis of Inv expres-
sion) or 37C (analysis of YadA expression). Pellets were
resuspended in H2O and Laemmli buffer (Bio-Rad) to
obtain 5£106 bacteria/ml. Samples were boiled for
10 min at 95C before loading on the gel. After SDS-
PAGE proteins were transferred onto nitrocellulose
membranes. The membranes were blocked overnight
with 5% milk powder in PBS at 4C. Membranes were
probed with antisera against Inv (rabbit anti-Inv,
1:2000), YadA (rabbit anti-YadA, 1:1000), OmpA (rabbit
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anti-OmpA, 1:1000), OmpF (rabbit anti-OmpF, 1:1000),
BamB (rabbit anti-BamB, 1:1000) and RNA-Polymerase
b subunit (mouse anti-RNA-Polymerase, Neoclone,
1:1000) and secondary antibodies goat anti-rabbit IgG
DyLight 680 conjugate or goat anti-mouse IgG DyLight
800 conjugate (Thermo Fisher scientiﬁc). For detection
of bands, the Odyssey imaging system (Li-Cor Bioscien-
ces) was used.
Quantiﬁcation of Inv and YadA surface display by
ﬂow cytometry
After growth for 4 h at 27C (analysis of Inv expression) or
37C (analysis of YadA expression), 5£107 bacteria were
harvested, washed with PBS, ﬁxed with 4% paraformalde-
hyde and blocked with 1% BSA in PBS. Cells were incubated
with rabbit anti-Inv or rabbit anti-YadA (1:200) antibodies
overnight at 4C followed by incubation with secondary
antibody donkey anti rabbit-APC (1:200, Jackson Immu-
noResearch) for 1 h at room temperature. Surface display of
Inv or YadA was measured by ﬂow cytometry using an
LSRFortessa cell analyzer (BD Biosciences). Data were ana-
lyzed withWinMDI (J. Trotter) software.
RNA extraction and quantitative real-time PCR
RelativemRNA levels of target genes were determined using
quantitative real-time PCR (RT-PCR). Bacteria were grown
for 4 h at 27C (for veriﬁcation of deletions at mRNA level)
or at 37C (for quantiﬁcation of mRNA levels in relation to
the MS data which were obtained at 37C) in LB medium.
RNA of bacteria was isolated using the RNeasy Mini Kit
(Qiagen) according to the manufacturer protocol. Genomic
DNA was digested with DNAseI (recombinant, RNAse free
10 Uml; Roche). Primer pairs used for RT-PCR are listed in
the category “Veriﬁcation of deletions (qRT-PCR)” and
“Quantiﬁcation of expression levels of selected OMPs” in
Table S2. For quantitative RT-PCR the Brilliant II SYBR©
Green 1-StepMasterMix (Agilent) was used. Relative quan-
tiﬁcations were performed with a LightCycler480II instru-
ment (Roche). For determination of transcriptional levels of
target genes with the expression of gyrB as a reference the
advanced relative quantiﬁcation tool of the LightCycler480
software 1.5 was used. Experiments were performed three
times independently.
NanoLC-MS/MS analysis
OM protein fractions were subjected to 1D SDS-PAGE
and stained with Coomassie Brilliant blue (Bio-Rad) for
1 h followed by destaining. Lanes were cut into three sli-
ces of comparable size and digested in gel with trypsin as
described previously.49 Peptide mixtures were separated
on the EasyLC nano-HPLC (Proxeon Biosystems) cou-
pled to an LTQ Orbitrap XL (Thermo Fisher Scientiﬁc).
Binding and chromatographic separation of the peptides
was performed on a 15 cm fused silica emitter with an
inner diameter of 75 mm (Proxeon Biosystems), in-
house packed with reversed-phase ReproSil-Pur C18-AQ
3 mm resin (Dr. Maisch GmbH). The peptide mixtures
were injected in HPLC solvent A (0.5% acetic acid) at a
ﬂow rate of 500 nl/min and subsequently eluted with an
127 minute segmented gradient of 5–33–50–90% of
HPLC solvent B (80% acetonitrile in 0.5% acetic acid) at
a ﬂow rate of 200 nl/min. The mass spectrometer was
operated in the data-dependent mode to automatically
switch between MS and MS/MS acquisition. Precursor
ions were acquired in the mass range from m/z 300 to
2000 in the Orbitrap mass analyzer at a resolution of
60.000. Accumulation target value of 106 charges was set
and the lock mass option was used for internal calibra-
tion.50 The 10 most intense ions were sequentially iso-
lated and fragmented in the linear ion trap using
collision-induced dissociation (CID) at the ion accumu-
lation target value of 5000 and default CID settings. The
ions already selected for MS/MS were dynamically
excluded for 90 s. The resulting peptide fragment ions
were recorded in the linear ion trap.
MS data processing and analysis
Acquired MS spectra were processed with MaxQuant
software package version 1.5.2.851 with integrated
Andromeda search engine.52 Database search was per-
formed against a target-decoy Ye serotype O:8 speciﬁc
database obtained from Uniprot, containing 4172 pro-
tein entries, and 245 commonly observed contaminants.
This database did not include an entry for TolC. There-
fore, data were also analysed with a Ye Uniprot database
containing 23,675 protein entries. Endoprotease trypsin
was deﬁned as the protease with a maximum missed
cleavage of two. Oxidation of methionines and N-termi-
nal acetylation were speciﬁed as variable modiﬁcations,
whereas carbamidomethylation on cysteines was deﬁned
as a ﬁxed modiﬁcation. Initial maximum allowed mass
tolerance was set to 4.5 ppm (for the survey scan) and
0.5 Da for CID fragment ions. A false discovery rate of
1% was applied at the peptide and protein level. The
label-free algorithm was enabled, as was the “match
between runs” option.53 MaxQuant output table was ﬁl-
tered for OM proteins (lipoproteins and ß-barrel pro-
teins). Fourty-seven OM proteins could be identiﬁed and
were kept for further analysis. Perseus software (version
1.5.0.15), a module from the MaxQuant suite,51 was used
for calculation of the signiﬁcance B (psigB) for each pro-
tein ratio (calculated based on averaged LFQ intensities)
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with respect to the distance of the median of the distribu-
tion of all protein ratios as well as its LFQ intensity. All
proteins with psigB < 0.05 in a pairwise comparison
were considered to be differentially expressed. The mass
spectrometry proteomics data have been deposited to the
ProteomeXchange54 Consortium via the PRIDE55 part-
ner repository with the dataset identiﬁer PXD004429
(http://proteomecentral.proteomexchange.org/cgi/GetDa
taset Username: reviewer56328@ebi.ac.uk Password:
XBxYXb4E) and in Table S4. Hydropathy indices of pro-
teins were calculated using the tool http://www.gravy-cal
culator.de/.
LPS analysis
LPS analysis was performed as described previously56,57
using 4% stacking and 12% separating deoxycholate–
polyacrylamide gel electrophoresis (DOC-PAGE). After
the run the material was visualized by silver staining.58
Quantiﬁcation of O-antigen surface display by ﬂow
cytometry
After growth for 4 h at 27C, 1£108 bacteria were harvested,
washed with PBS, ﬁxed with 4% paraformaldehyde and
blocked with 1% BSA in PBS. Cells were incubated with Ye
O:8-antigen-speciﬁc mouse Fu26–1F1–1 (1:20) monoclonal
antibody59 overnight at 4C followed by incubation with
secondary antibody goat anti mouse IgG Cy2 (1:200,Dia-
nova) for 1 h at room temperature. Surface display of
O-antigen was measured by ﬂow cytometry using an
LSRFortessa cell analyzer (BD Biosciences). Data were ana-
lyzed withWinMDI (J. Trotter) software.
Microscopy
For preparation of electron microscopy pictures bacteria
were grown at 37C for 5 h, ﬁxed in Karnovsky’s ﬁxative,
embedded in agarose, coagulated, cut in small blocks and
ﬁxed again in Karnovsky’s solution. After post-ﬁxation
and embedding in glycid ether blocks were cut using an
ultramicrotome. Sections (30 nm) were mounted on cop-
per grids and analyzed using a Zeiss LIBRA 120 trans-
mission electron microscope.
Mouse infection experiments
Mouse infection experiments were performed according to
German law with permission of the Regierungspr€asidium
T€ubingen (permission number H1/14). Groups of ﬁve
female C57/Bl6 mice (Harlan) of similar age (6–8 weeks)
and weight (»17 g), were injected intraveniously with
1£105 Ye wildtype or mutant bacteria in PBS that had been
grown for 4 h at 37C. Mice were sacriﬁced after one or
three days post infection and the colony forming units
(CFU) in the spleen were determined. For oral infection
groups of seven BALB/c mice (Harlan) of similar age (6–
8 weeks) and weight (»17 g) were fed 1£108 Yewildtype or
mutant bacteria in PBS that had been grown for 4 h at 27C.
At one, three and ﬁve days post infection the CFU in feces
were determined. At day ﬁve post infection mice were sacri-
ﬁced and the CFU in spleen, peyers patches and mesenteric
lymph nodes were determined. Organs were homogenized
in 4 ml (spleen), 2 ml (peyers patches) or 1 ml (mesenteric
lymph nodes and feces) sterile PBS (Life Technologies). The
number of bacteria and the detection limit were determined
as described previously.60 The detection limit of CFU per
gramwas 500 (log10 500D 2.69; spleen), 1000 (log10 1111D
3.05; peyers patches), 333 (log10 333 D 2.47; mesenteric
lymph nodes) and 654 (log10 654D 2.8; feces).
Serum killing assay
Normal human serum (NHS) was collected from at least 4
healthy volunteers and pooled. The IgG and IgM antibody
titer against Yersinia in serum was tested by ELISA. Only
IgG and IgM negative pooled serum was used throughout
the experiments. Aliquots were stored at¡80C and thawed
only once. Heat inactivated serum was generated by incu-
bating the serum at 56C for 30 min immediately before
use. To analyze the susceptibility of Ye against complement
mediated killing, 5£106 bacteria were incubated in 5% HIS
or NHS for 15 min at 37C. After that the samples were
placed on ice for 5 min and an equal volume of brain heart
infusion medium was added to stop complement activity.
Serial dilutions of the samples were prepared and plated on
selective agar plates. After incubation at 27C for 24 h CFU
were determined by counting.
Statistics
Data are means § SD. Statistical analysis was carried out
using GraphPad Prism 5 (GraphPad Software, La Jolla,
CA) applying one-way ANOVA analysis with either
Dunetts multiple comparison test or with a Kruskal
Wallis test and Dunns multiple comparisons test as
described in the ﬁgure legends. Differences were consid-
ered signiﬁcant if p  0.05, p  0.01, p  0.001.
Results
Generation of knockout strains and impact of
knockouts on growth of Ye
In order to address the importance of BamB, BamC,
BamE, DegP, SurA and Skp for ﬁtness and virulence of
1174 J. WEIRICH ET AL.
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Ye, we generated single gene knockouts by a mating and
homologous recombination strategy using a suicide plas-
mid (see Materials and Methods section for details). To
this end we used the strain Ye WA-314.61 The resulting
single gene knockout strains were veriﬁed by PCR using
genomic DNA as template (Fig. 1A). PCR products
obtained with the knockout strains had the size expected
for successful deletion. Additionally, the presence of
mRNA transcripts was analysed by realtime RT-PCR
(Fig. 1B). mRNA transcripts for the targeted genes were
not detectable in the knockout strains. The presence of
protein was tested by Western blots using antibodies
raised against the corresponding E. coli proteins. How-
ever, only the BamB and BamC-speciﬁc antibodies did
cross-react with the Yersinia proteins (Fig. 1C). Though,
PCR and RT-PCR clearly demonstrate that our single
gene deletions were successful for all targeted genes. To
test if the individual knockout of BamB, BamC, BamE,
SurA, DegP, or Skp had a general impact on Ye growth
at host temperature, we performed growth curves at
37C (Fig. 2A). Compared to the wildtype strain only the
BamB deﬁcient strain displayed slightly reduced growth.
This turned obvious at 4 h after inoculation and sus-
tained throughout recording of the growth curve
Figure 1. Veriﬁcation of knockout strains. (A) Genomic DNA of indicated strains was isolated and the deletion of target genes was veri-
ﬁed by PCR. The expected product sizes are indicated in the table on the right-hand side. (B) Total RNA was extracted from Ye wildtype
and the different mutant strains. The deletion of target genes was veriﬁed by qRT-PCR using gyrA as reference gene. (C) Ye whole cell
lysates were probed with antibodies raised against E. coli BamB or BamC that exhibited cross-reactivity with the respective Ye proteins
(all other available antibodies did not cross-react with the Ye homologs). The calculated molecular weight of the tested proteins from E.
coli and Ye homologs are indicated in the table on the right-hand side.
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(Fig. 2B). The growth phenotype of the DbamB strain
could be rescued by ectopic constitutive expression of
BamB from a plasmid (Fig. 2B, Ye DbamB-pACYC).
Assessment of OM integrity
There are different means to assess the integrity and per-
meability barrier function of the Gram-negative OM.
Usually the OM of Gram-negatives quite effectively
excludes several antibiotics from entry into the cell. It
was reported earlier that the loss of BamB in E. coli leads
to an increase in the susceptibility against various antibi-
otics as a result of increased permeability of the OM.48,62
We therefore investigated the susceptibility of the differ-
ent Ye knockout strains to the antibiotics rifampicin,
erythromycin, vancomycin and bacitracin using a disk
diffusion assay (Table 1). We found that the sensitivity
of the DbamC and the DdegPmutant strains to all antibi-
otics used was comparable to that of the wildtype strain,
whereas the DbamE mutant showed increased suscepti-
bility to erythromycin. Also the Dskp mutant was more
sensitive to erythromycin compared to the wildtype
strain. Additionally, the inhibition zone around the van-
comycin disk was hazy, which could mean that the con-
centration of vancomycin was subinhibitory for this
mutant. More striking phenotypes were observed with
the DbamB mutant that displayed increased sensitivity to
rifampicin, erythromycin, vancomycin but not to baci-
tracin. The greatest impact on antibiotic sensitivity was
observed in the DsurA mutant strain that displayed
increased sensitivity to all four antibiotics tested as com-
pared to the wildtype strain. By introducing plasmids
harbouring wildtype bamB, surA or skp into the corre-
sponding deletion strains the wildtype phenotype could
be restored at least partially. These results demonstrate
that in Ye the loss of either BamB or SurA signiﬁcantly
enhances the efﬁcacy of selected antibiotics. The
observed effect is most likely the result of impaired OM
integrity. Skp and BamE seem to play only minor or
redundant roles in keeping up OM integrity. The loss of
BamC or DegP did not affect the OM permeability in
our hands.
Another possibility to assess the integrity and func-
tion of the OM is to challenge the bacteria with deter-
gents like bile salts or SDS. As for antibiotics, the OM
usually is an efﬁcient barrier for these substances.62,63,64
Figure 2. Growth of single-gene knockout strains. Bacteria were
grown at 37C for 9 h in LB. Samples were taken every 30 min
and the OD of appropriate dilutions was determined at 600 nm.
(A) Comparison of growth of the parent strain Ye wildtype, all
mutant strains Ye DbamB, DbamC, DbamE, DdegP, DsurA and
Dskp and the complemented mutants Ye DbamB-pACYC, DsurA-
pACYC and Dskp-pACYC. (B) Growth curves of Ye wildtype strain,
DbamB strain and DbamB strain carrying wildtype BamB on a
plasmid (DbamB-pACYC).
Table 1. Sensitivity of knockout strains against antibiotics, bile
salts and SDS.
Zone of
inhibition
Growth on
MacConkey agar Growth
on SDSStrain/
Antibiotic
substance
Rif
(5 mg)
Ery
(15 mg)
Van
(30 mg)
Ba
(10 mg) x10¡2 x10¡3 x10¡4
0,0125
%
Ye wildtype 10 10 6 6 R R R C
Ye DbamB 20 16 20 6 R S S ¡
Ye DbamB
pACYC-
bamB
10 10 6 6 R R R C/¡
Ye DbamC 10 10 6 6 R R R C
Ye DbamE 10 12 6 6 R R R C
Ye DdegP 10 8 6 6 R R R C
Ye DsurA 18 18 16 16 R S S C/¡
Ye DsurA
pACYC-
surA
10 12 6 6 R R R C
Ye Dskp 10 12 6 (hazy) 6 R R R C
Ye Dskp
pACYC-
skp
10 10 6 6 R R R C
Antibiotic sensitivity was determined by a disk diffusion assay as described in
material and methods. The diameter of the inhibition zone around the disk
(diameter 6 mm) was measured and is shown in mm. Rif D Rifampicin, Ery
D Erythromycin, Van D Vancomycin, Ba D Bacitracin. Sensitivity to bile salts
and SDS was assessed by the ability of the bacteria to grow on plates con-
taining these compounds as described in material and methods section.
Growth of the strains in the presence of bile salts is indicated by (R),
whereas strains that did not grow are labeled by (S). Growth of the strains in
the presence of SDS is indicated by a (+), whereas strains that did not grow
are labeled by (¡).
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We therefore tested growth of the different knockout
strains on MacConkey agar, which contains bile salts, or
agar containing SDS. We found that the sensitivity of the
DbamC, DbamE, DdegP and Dskp mutants to bile salts
and SDS was comparable to wildtype (Table 1). In con-
trast, the DbamB and the DsurA mutants displayed
increased sensitivity to both bile salts and SDS compared
to the wildtype strain. Again, these phenotypes were
restored by introducing wildtypic bamB or wildtypic
surA into the corresponding mutants. Overall these
results corroborate our ﬁndings obtained by the disk dif-
fusion assays and demonstrate that BamB and SurA are
essential for maintaining envelope integrity in Ye. More-
over, BamB and SurA seem to fulﬁll non-redundant
functions, whereas BamC, BamE, DegP and Skp appear
to play only a minor role.
OM protein composition of knockout strains
OM integrity is signiﬁcantly determined by OMP abun-
dance and composition.18,62,65 As we had observed that the
OM integrity is disturbed in some of the mutant strains we
wanted to get a more in-depth view into their OMP proﬁle.
To do so, we prepared OMP fractions of equal bacterial
numbers as described elsewhere66 and assessed gross OMP
composition by SDS-PAGE and Coomassie blue staining.
We found that the pattern and the intensity of numerous
bands in all knock-out strains differed to variable extent
compared to the wildtype strain (Fig. 3A). The most notice-
able effect was observed in the DbamBmutant strain where
the levels of almost all OMPs were drastically reduced. To
get a more comprehensive insight into which set of OMPs is
affected by the absence of BamB, SurA or Skp (i.e. the strains
which had shown some phenotype in the experiments car-
ried out before) we performed proteome analysis of OM
fractions and compared it to the wildtype strain (Fig. 3B,
coloured columns). Semiquantitative proteomic analysis
was performed using tryptic in-gel digestion and LC-MS/
MS analysis. We could identify 47 OMPs (lipoproteins and
ß-barrel proteins; for sake of clarity only some of these are
included in Fig. 3B; for the full list please refer to http://pro
teomecentral.proteomexchange.org/cgi/GetDataset using
the Dataset Identiﬁer PXD004429 or Table S4), that were
kept for further analysis. Compared to Ye wildtype six
OMPs were identiﬁed as having signiﬁcantly higher or
lower signal intensities by applying a stringent selection
(p < 0.05). In the DbamB mutant strain BamE (Protein
ID A1JKI3: log2 DbamB/WT D 3.12) and a OmpA-C
like protein (Protein ID A1JT57: log2 DbamB/WT D
4.21) were signiﬁcantly more abundant, in the Dskp
Figure 3. Changes in OM protein composition upon loss of BamB, BamC, BamE, DegP, SurA or Skp. (A) OM proteins were separated on
an SDS-PAGE and stained with Coomassie brilliant blue. Gross changes in OMP pattern and intensity of individual bands can be
observed. (B) Semiquantitative changes in the abundance of 19 OMPs of Ye DbamB, DsurA or Dskp as assessed by mass spectrometry.
The log2 (mutant/Ye wildtype)-fold change of LFQ intensities is shown, comparing Ye DbamB, DsurA or Dskp with Ye wildtype. Data are
means of three independent experiments. TolC was not present in the Ye serotype O:8-speciﬁc database that was initially used for anal-
ysis of the mass spectrometry data. Therefore, data had to be reanalysed using a different Ye (not serotype-speciﬁc) database that
included also TolC. Corresponding mRNA levels were determined using gyrB as a reference gene (relative quantiﬁcation) in three inde-
pendent experiments. Ratios were then calculated as log2 (mutant/Ye wildtype) using relative mRNA concentrations that were calcu-
lated based on Cp values and a standard curve comparing Ye DbamB, DsurA or Dskp with Ye wildtype. Increased mRNA levels are
indicated as C (increase; 0.335 to 1.27). Unchanged mRNA levels are indicated as D (no change; ¡0.6 to 0.335). Decreased mRNA levels
are indicated as -- (strong reduction; ¡2.47 to¡1.535) or - (reduction; ¡1.535 to¡0.6). LPD lipoprotein, CR D complement resistance,
na D not assessed. The number of b-strands composing the OMP b-barrels is indicated as well as the GRAVY (grand average of protein
hydropathy) and the function that has been assigned to the individual proteins.
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mutant strain we found a membrane-bound lytic murein
transglycosylase A precursor (Protein ID A1JPB3: log2
Dskp/WT D 1.57) and a starvation-inducible outer
membrane lipoprotein (Protein ID A1JRD0: log2 Dskp/
WT D 0.87) at signiﬁcantly higher intensities. In both
the DsurA and Dskp mutant strains, FyuA (Protein ID
A1JTG3: log2 DsurA/WT D ¡4.10; log2 Dskp/WT D
¡2.36) was signiﬁcantly less abundant. Additionally, we
observed a signiﬁcant reduction of Inv (Protein ID
A1JT35: log2 DsurA/WT D ¡4.37) in the DsurA mutant
strain. Being especially interested in the effects of the
knockouts on the abundance of virulence factors, the
BAM itself and the most abundant OMPs we generated a
summary about the effects on protein levels shown as
the log2 (mutant/Ye wildtype)-fold change of label-free
quantiﬁcation (LFQ) intensities (Fig. 3B). To decipher if
the observed changes in protein abundance might be
attributed to downregulation of gene expression, we
assessed the relative mRNA levels of representative can-
didates in the bamB, surA or skp deletion mutants by
quantitative RT-PCR (Fig. 3B; changes in mRNA levels
are indicated by C, D, -- and –; for precise numbers
please refer to Table S3). As expected, a reduction of
mRNA was associated with reduced abundance of pro-
tein for all of the highly abundant major OMPs we tested
(OmpA, OmpF, LamB). Interestingly, we found that in
some cases the strong reduction of protein abundance
could not be explained by massive downregulation of
mRNA expression. This holds true for Inv and FyuA in
the DsurA and LptD in the DbamB, DsurA and Dskp
mutant strain. Inv, FyuA and LptD might thus be
deﬁned as “true” substrates of SurA, strictly relying on
its presence in order to be inserted efﬁciently into the
bacterial OM. We also found that in the DbamB mutant
all BAM-complex components were more abundant in
the OM whereas the corresponding mRNA levels were at
wildtype levels. A possible explanation for this is that
upon the downregulation of the highly abundant porins
(OmpA, C, F, X and LamB) the spectrum of BAM sub-
strates changes profoundly. Consequently, other BAM
substrates whose mRNA expression remains unchanged
- such as BamA - are inserted into the OM at a higher
rate. This might result in the assembly of more BAM
complexes in the OM of the DbamB mutant strain com-
pared to the wildtype strain. Taken together, we identi-
ﬁed the Ye virulence factor Inv as a new true substrate of
SurA and ﬁgured out that also other important OMPs
that contribute either to virulence or bacterial ﬁtness (i.e.
FyuA as the receptor for Yersiniabactin that is decisive
for efﬁcient iron uptake;67 and LptD, an essential protein
in E. coli that is involved in LPS transport68 are less
abundant in the mutant strains. Their loss might conse-
quently inﬂuence the virulence especially of the Ye
DbamB, DsurA and possibly also of the Dskp mutant
strain.
Expression and surface presentation of Inv and YadA
in knockout strains
One interesting ﬁnding of our MS analyses was that
YadA and Inv were affected to different extent by the
knockout of bamB, surA or skp. Both YadA and Inv
belong to the same membrane protein family that con-
sists of numerous virulence factors and is termed the
type V secretion system,8,9,69 also called autotransporters
(AT). Whereas YadA belongs to the type Vc AT and
forms trimers, Inv is a monomeric, inverted AT belong-
ing to the type Ve AT. Both YadA and Inv are known to
be inserted into the OM BAM-dependently70,71 and both
are anchored to the OM by a 12-stranded b-barrel (con-
sisting of 3 monomers contributing 4 b-strands each in
the case of YadA). Thus, we wondered why Inv biogene-
sis was affected more severely by the absence of BamB or
SurA than that of YadA. To this end, we ﬁrst wanted to
verify our MS data by quantiﬁying the OM abundance of
YadA and Inv by other means. We prepared whole cell
lysates and performed Western blots and additionally
carried out ﬂow cytometry analysis with intact bacteria
using antibodies directed against the passenger domains
of YadA or Inv, respectively (Fig. 4). Whereas YadA pro-
tein levels were hardly affected by any of the knockouts
(Fig. 4A), we observed a clear reduction of the Inv total
protein amount in the Ye DbamB (Fig 4C, upper panel)
and DsurA (Fig 4B, upper panel) strains and conse-
quently also of passenger domain surface display as
assessed by ﬂow cytometry (Fig. 4B and Fig 4C, lower
panel). This reduction could be restored by the ectopic
expression of SurA from a plasmid (samples labelled -
pACYC for complementation). However, in the case of
BamB it seemed that the expression level achieved with
this plasmid was not adequate to complement for the
absence of BamB in the bacterial chromosome. There-
fore, we generated another plasmid for the complemen-
tation of the DbamB mutant strain that allowed
inducible expression and therefore titration of the
amount of BamB produced. Using this plasmid the
reduction of Inv could be restored in the DbamB mutant
strain. Taken together, it seems that the BAM complex
can efﬁciently catalyze YadA b-barrel assembly and OM
insertion even in the absence of BamB or SurA. In the
case of YadA, SurA and Skp thus seem to fulﬁll redun-
dant roles. To verify this ﬁnding we attempted to gener-
ate a surA-skp double knockout mutant, but the deletion
of both chaperones seems to be synthetically lethal in Ye.
This observation has been described before for E. coli.72
In contrast, the efﬁcient folding and insertion of Inv is
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Figure 4. Differential impact of single gene knockouts on YadA and Inv protein levels and surface presentation. (A upper panel) Ye wild-
type and the different mutant strains were grown in LB. Whole cell lysates were separated by SDS-PAGE, transferred to a nitrocellulose
membrane and probed with antibodies raised against YadA. As a loading control, all samples were probed with antibodies directed
against bacterial RNA-Polymerase I (RNA-Pol.). (A lower panel) Flow cytometry analysis of YadA cell surface exposure was investigated
using antibodies directed against YadA. Bar charts show values of the mean ﬂuorescence intensities C/¡ SD of 3 independent bacterial
cultures. (B upper panel) Western blot analysis of Ye whole cell lysates as described above, but probed with anti-Inv antibodies. (B lower
panel) Flow cytometry analysis of Inv cell surface exposure was carried out using antibodies directed against Inv. (C upper panel) West-
ern Blot analysis of Ye whole cell lysates as described above for Ye wildtype, DbamB, DbamB-pIBA and DInvasin strains, using antibodies
directed against Inv, BamB and RNA-Pol. (C lower panel) Flow cytometry analysis of Inv cell surface exposure in Ye wildtype, DbamB,
DbamB-pIBA and DInvasin strains was carried out as described above. Bar charts show values of the mean ﬂuorescence intensities C/¡
SD of 3 independent bacterial cultures. The main p value was determined by one-way ANOVA (B, ﬂow cytometry: p < 0.0001). Multiple
comparisons were performed by one-way ANOVA with a Dunnett’s multiple comparisons test and the p values are indicated with aster-
isks. p  0.05; p  0.01, p  0.001.
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signiﬁcantly impaired if BamB or SurA are absent. Possi-
ble reasons for this will be discussed later.
Morphology of selected knockout strains
So far, our experiments demonstrated that the deletion of
BamB, SurA and, to a lesser extent, of Skp lead to
changes in the OM integrity and abundance of selected
OMPs. As the OM composition is intrinsically tied to
shaping of the bacterial morphology, we asked whether
our mutant strains displayed visible morphological
changes. To address this question we prepared electron
microscopy pictures of the Ye wildtype and the DbamB,
DsurA and Dskp mutant strain. In the Ye DbamB, the
DsurA and the Dskp mutant strains we observed the for-
mation of outer membrane vesicles (OMVs; Fig. 5). The
phenotype seemed to be somehow less pronounced in
the Dskp mutant. The release of OMVs is a common
mechanism of all Gram-negative bacteria to secrete OM
and periplasmic material73 and serves as an indicator for
cell envelope stress.74 Thus, our results indicate that the
loss of BamB, SurA or Skp induces cell envelope stress
and the accumulation of envelope components in Ye,
which may then be released from the cell surface con-
tained in OMV.
Impact of knockouts on Ye virulence in mouse
infection
All our data obtained point at a profound change in OM
integrity and OMP composition upon the loss of BamB,
SurA and Skp. Therefore, we wanted to know how these
changes translate into overall virulence of Ye. In order to
assess the effect of the individual deletions of BamB,
BamC, BamE, DegP, SurA or Skp during systemic infec-
tion, we injected female C57BL/6 mice intravenously
with Ye. The bacterial burden (CFU) in the spleen was
assessed one and three days post infection (Fig. 6A, left
panel). One day post infection the Ye wildtype strain
resulted in a bacterial burden of 7.33 § 0.42 log10 per
gram spleen whereas bacterial counts were below detec-
tion limit in the spleens of mice infected with the DbamB
mutant (p < 0.001). The DbamC (7.32 § 0.12 log10
CFU), the DbamE (7.01 § 0.34 log10 CFU) and the
DdegP (7.61 § 0.14 log10 CFU) mutant strains exhibited
CFU comparable to the wildtype. The DsurA (3.97 §
0.33 log10 CFU; p < 0.01) strain was signiﬁcantly attenu-
ated, whereas the Dskp (6.97 § 0.33 log10 CFU) mutant
was only slightly attenuated. To ﬁgure out the further
development of the CFU of the DsurA and the Dskp
mutant strains we assessed the bacterial burden in the
spleen also at three days post infection (Fig. 6A, right
panel). We were not able to detect Ye DsurA (p < 0.01)
in the spleens of mice at this later timepoint. The CFU of
the Dskp mutant strain (5.38 § 3.23 log10 CFU; p 
0.01) was still below wildtype levels (9.77 § 0.11 log10
CFU). This indicates that both the Dskp and the DsurA
mutant are not able to replicate at wildtype levels in the
host and are cleared more efﬁciently by the host.
The systemic mouse infection model is very helpful to
determine the overall pathogenic potential of a Ye strain.
However, the natural route of Ye infection is orogastric.
In contrast to systemic infection where the bacteria are
immediately confronted with host immune cells and also
the complement system, stressors are rather different in
the oral infection model. Here, the bacteria have to cope
with the passage through the stomach and gut and to
compete with the endogenous microbiota. To test how
our mutant strains behave under these circumstances,
we infected mice orally with the Ye wildtype strain or the
DbamB, DsurA or Dskp mutant strains (Fig. 6B). The
bacterial burden in feces was then determined at one,
three and ﬁve days post infection. In animals infected
with the wildtype strain we measured a bacterial burden
of 5.52 § 1.79 log10 CFU per gram feces at day one post
infection. At day three and ﬁve the bacterial numbers
Figure 5. Deletion of bamB, surA and skp leads to formation of OMV. Ye wildtype and the different mutant strains were grown in LB,
ﬁxed with Karnovsky-solution and then analysed by electron-microscopy. Scale bars correspond to 0,2 mm.
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had increased (6.86 § 1.30 log10 CFU at day 3; 8.71 §
0.35 log10 CFU at day 5). In contrast, we found that the
bacterial numbers were slightly lower in animals infected
with DbamB (3.23 § 0.83 log10 CFU), DsurA (4.02 §
1.56 log10 CFU) and Dskp (3.04 § 0.47 log10 CFU)
mutant strains at day one post infection. After three days
Figure 6. Impact of single gene knockouts on virulence of Ye. (A left panel) C57BL/6 wildtype mice were infected intravenously with Ye
wildtype and the different mutant strains. Bacterial burden in the spleen was determined one day post infection. (A right panel) C57BL/
6 wt mice were infected intravenously with Ye wildtype, DsurA and Dskp mutant strains. Bacterial burden in the spleen was determined
three days post infection. (B) Balb/C mice were infected orally with Ye wildtype, DbamB, DsurA and Dskp mutant strains. Bacterial bur-
den in feces was determined one, three and ﬁve days post infection. (C) At ﬁve days post infection the bacterial burden in peyers
patches and mesenteric lymph nodes was also determined. The p value for the comparison of wildtype and mutant strains was deter-
mined by one-way ANOVA (p< 0.0001). Multiple comparisons were performed by one-way ANOVA with a Kruskal Wallis test and Dunns
multiple comparisons test and the p value is indicated with asterisks. The horizontal lines denote the mean, the error bars the SD.  p
0.05,  p  0.01,  p  0.001, n D 5–17.
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the CFU of the DbamB (p  0.05) and the DsurA (p 
0.001) mutant strains dropped below our detection limit.
The Dskp mutant was still detectable at day three and
ﬁve but at slightly lower CFU compared to the wildtype
strain (5.27 § 1.16 log10 CFU at day 3; 6.15 § 1.04 log10
CFU at day 5). These results demonstrate that the
DbamB and DsurA mutant are able to reach the gut, but
are then cleared more efﬁciently. To analyze the ability
of the mutant strains to disseminate from the gut into
peyers patches and subsequently into the mesenteric
lymph nodes and spleen, we also determined the CFU in
these organs after ﬁve days of infection (Fig. 6C). In the
peyers patches, the DbamB (p  0.01) and the DsurA (p
 0.001) mutant strains were not detectable, whereas Ye
Dskp (6.39 § 0.80 log10 CFU/ g tissue) was detectable,
but with slightly lower CFU compared to the wildtype
(7.98 § 1.89 log10 CFU/ g tissue). In the mesenteric
lymph nodes we were able to detect wildtype only (4.54
§ 4.15 log10 CFU). The results of our animal infection
models demonstrate that DbamB and DsurA are unable
to disseminate, whereas the Dskp mutant is able to enter
the peyers patches but cannot disseminate to the mesen-
teric lymph nodes. We could not detect any bacteria in
the spleen ﬁve days after oral infection. Overall these
data show that the loss of BamB or SurA and to a lesser
degree Skp leads to attenuation of Ye in both systemic
and oral infection.
Serum killing assay
One important virulence trait of Ye is serum resistance. Ye
has evolved a multitude of mechanisms to evade the action
of the serum complement and can therefore withstand com-
plement-mediated lysis quite efﬁciently.39,40,41,42 Therefore,
we wondered if this aspect of Ye virulence is inﬂuenced in
the strains that were signiﬁcantly attenuated in systemic
infection and might thus explain the ﬁndings of our animal
infection experiments. To compare the serum resistance of
wildtype and the DbamB, the DsurA and the Dskp mutant
strains we carried out serum killing assays (Fig. 7). Actually,
we found that the DbamB, the DsurA and the Dskpmutant
(although to a lesser extent) are highly susceptible to serum
killing. We could restore this serum sensitivity phenotype
by ectopic expression of BamB, SurA or Skp from plasmids.
For complementation of the DsurA and the Dskp strain we
used a plasmid (pACYC) that leads to constitutive expres-
sion of SurA or Skp respectively. For BamB we used an
inducible plasmid, since the constitutive expression of
BamB from a plasmid did not restore the phenotype. Serum
sensitivity could be a decisive factor explaining the quick
elimination of the DbamB, DsurA and the Dskp mutant
strains in the systemic infection model either due to
enhanced direct lysis by the terminal complement complex
or due tomore efﬁcient opsonophagocytosis.
Discussion
In our study we wanted to investigate if single BAM-
complex components and periplasmic chaperones could
serve as targets to develop antivirulence drugs. We could
show that SurA and BamB are key factors for virulence
of Ye and might therefore serve as good candidates.
Their loss led to signiﬁcant attenuation in a mouse infec-
tion model and signiﬁcantly enhanced killing by NHS.
BamB and SurA are not only key factors determining vir-
ulence of Ye, but also in a number of other important
Gram-negative pathogens. The importance of BamB has
been described for E. coli and Salmonella.62,75 A key role
of SurA for virulence was reported also for Salmonella
enterica,76,77 Shigella ﬂexneri,78 uropathogenic E. coli,79,80
Yersinia pseudotuberculosis15,81 and Yersinia pestis.82
Thus the spectrum of pathogens that could be treated by
Figure 7. Ye DsurA, DbamB and Dskp are more susceptible to
serum killing. Serum killing assay of Ye wildtype, DsurA, DbamB
and Dskp mutant and complemented strains thereof. As a full
rescue of the absence of bamB could not be achieved by pACYC,
we additionally included a rescue with an inducible plasmid
(pIBA). Bacteria were incubated in HIS or NHS. After stopping the
reaction the samples were plated on selective agar plates and
the CFU was determined. The bar chart depicts the percentage of
survival in comparison to samples incubated in HIS in parallel
(100% survival). Data are means § SD of at least three individual
experiments. The main p value was determined by one-way
ANOVA (p < 0.001). Multiple comparisons were performed by
one-way ANOVA with a Dunnett’s multiple comparisons test and
the p value is indicated with asterisks. p 0.05, p  0.01,
p  0.001, n D 4.
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new drugs that aim at reduction of virulence and
impairment of OM barrier could be extended or adapted
to a large range of Gram-negatives. In fact, the sequence
homology of BamB and SurA in a variety of enteropath-
ogens is quite high, particularly in the family of Entero-
bacteriaceae comprising e.g. Ye, E. coli, Salmonella
enterica or Klebsiella pneumoniae (70% protein sequence
identity and higher). Therefore, it is possible that a drug
that targets BamB or SurA of Enterobacteriaceae can hit
several pathogens. Besides targeting OM virulence fac-
tors of pathogens by interfering with their biogenesis a
drug inhibiting SurA or BamB may also be very helpful
to sensitize pathogens to treatment with available antibi-
otic substances due to the general membrane defect that
is induced. By lowering minimal inhibitory concentra-
tions we additionally could reduce the consumption of
antibiotics. This would be an important contribution to
the avoidance of the emergence of antibiotic resistance
and spread.
Our main interest here was to decipher the impact of
the knockouts of non-essential BAM proteins and peri-
plasmic chaperones on Ye virulence. Among the best-
studied virulence factors of Ye are its adhesins Inv and
YadA. We know that a deletion of Inv does not lead to
reduced virulence, however, the course of Ye infection is
somehow delayed in such mutant strains.33 In contrast,
YadA deﬁcient mutants are avirulent in mouse infection
models.31,60,83 Even a reduction of YadA molecules in
the OM may lead to a signiﬁcant decrease in virulence.60
However, we think that the reduced virulence of the
DbamB and DsurAmutant strains in the mouse infection
is confounded by several aspects of Ye virulence. One
candidate protein that has been shown to be required for
full virulence of Ye in mice is the iron uptake receptor
FyuA.67,84 FyuA abundance was strongly affected in the
DsurA strain, also in the Dskp and to a lesser extent in
the DbamB mutant strain and might thus contribute to
reduced virulence. Another important virulence trait of
Ye is serum resistance. The main factor determining
serum resistance is YadA,39,40,41,42 but also LPS and Ail
have been shown to contribute.39,56 However, since both
YadA and Ail protein levels and surface display were
hardly affected in the DbamB and DsurA mutant strains
it is unlikely that changes in YadA or Ail abundance are
the reason for the rapid and efﬁcient serum killing we
have observed. Therefore, we suspected that changes in
LPS could contribute to this phenotype. However,
although we had observed profound changes in the
abundance of the LPS transport proteins LptD and LptE,
the amount of surface exposed LPS (as revealed by O-
antigen surface stainings; Fig. S1) of the DsurA and Dskp
mutant strain was comparable to wildtype. Thus,
enhanced serum killing does not seem to be an effect of
impaired LPS transport onto the bacterial surface at least
in the DsurA and Dskp mutant strain.
Actually, we found that in the DbamB mutant the LPS
phenotype indeed was altered, i.e., it lacked O-antigen,
whereas in the DsurA and Dskp mutant strains the O-
antigen structure was not signiﬁcantly different com-
pared to the wildtype bacteria (Fig. S1).
The O-antigen does not contribute directly to serum
resistance,40 however, it has been shown earlier that Ye lack-
ing LPS O-antigen are highly susceptible to serum kill-
ing.39,56 Strikingly, YadA expression levels were comparable
to wildtype in these strains.56 But even so, YadA-mediated
binding to extracellular matrix proteins (collagen I and lam-
inin) was reduced. It was hypothesized that this effect might
be induced by conformational changes in the YadA tertiary
structure caused by the absence of O-antigen. Such altera-
tions have been shown to inﬂuence the interaction of YadA
with collagen I.85 It is also conceivable that changes in the
YadA tertiary structure might directly inﬂuence the serum
resistance by changing the efﬁciency or the pattern of inter-
actions with negative regulators of complement (factor H,
C4BP, C3b, iC3b; reviewed in.86). This is intriguing, as we
have observed some time ago that a strain of Ye that
expresses a YadA version that carries a single point muta-
tion within its membrane anchor domain was present on
the bacterial surface at wildtype levels, but also displayed
reduced serum resistance.60 Also here, slight changes in ter-
tiary structure that might alter the interaction with comple-
ment regulatory factors were one possible reason for
explanation. Finally, an altered function of YadAmight also
be explained this way: the presence of O-antigen masks
other factors on the surface of Ye that efﬁciently compete
with YadA for the binding of ECM or serum proteins and
thereby induce reduced serum resistance.
We claim that also the general reduction of OMP
abundance might facilitate enhanced binding of terminal
complement complex factors, simply due to better acces-
sibility and possibly also due to changes in membrane
charge. Taken together, we provide evidence that
impaired serum resistance might contribute to the
enhanced clearance of both Ye DbamB and DsurA in the
systemic mouse infection model. The more pronounced
phenotype of Ye DbamB regarding CFU in spleen is in
good agreement with the greater importance of BamB
also in maintenance of OM barrier integrity as assessed
by sensitivity towards antibiotics, SDS and bile salts.
Moreover, the lack of O-antigen in the DbamB mutant
(Fig. S1) might also lead to further reduction of viru-
lence. Indeed, it was shown previously that the O-antigen
is a virulence factor in Ye and that a rough-mutant is
attenuated in mouse infection.87 In the orogastric infec-
tion model, the disrupted OM barrier function of Ye
DbamB and DsurA and the absence of O-antigen of Ye
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DbamB might preclude the survival of Ye during the gas-
trointestinal passage as both strains have increased sus-
ceptibility to detergents and are unable to grow at pH 4.5
(own observation).
Besides deciphering the effect on virulence we wanted
to investigate which effects the loss of single BAM-com-
plex components and periplasmic chaperones has on the
molecular level in Ye. We therefore analyzed the compo-
sition of OMPs and virulence factors. Data obtained by
mass spectrometry analysis allowed us some insight into
substrate preferences regarding BAM and periplasmic
chaperones. We found that the absence of SurA or BamB
led to signiﬁcantly reduced levels of Inv in the OM but
not of YadA, suggesting different contributions of these
factors to the biogenesis of Inv and YadA. The loss of
SurA or BamB signiﬁcantly reduced the surface display
of Inv, but did not alter the OM abundance of YadA.
Thus, we assume that Inv is a true substrate of SurA,
since its mRNA levels remained unchanged in the
absence of SurA, whereas the OM insertion was reduced.
Skp obviously is not able to take over the role of SurA
for Inv transit and delivery to the BAM. In contrast, the
decisive Ye virulence factor YadA can use both the chap-
erones SurA and Skp for periplasmic transit and BamB is
dispensable for its assembly and OM insertion. YadA
and Inv are both autotransporter adhesins with Inv being
a monomer and YadA being a trimer made of three iden-
tical subunits that together form a single ß-barrel. The
actual mechanism of how these autotransporters are
inserted and assembled into the OM via the BAM com-
plex is still not fully understood, but our results support
the hypothesis that the structural differences of Inv and
YadA result in different requirements for efﬁcient assem-
bly and insertion. YadA as a trimer is inserted indepen-
dently of BamB. This is in good agreement with ﬁndings
for another trimeric OMP of E. coli, namely TolC. TolC
is inserted independently of non-essential BAM proteins
and periplasmic chaperones65,88 but is strongly affected
by limitation of the essential BAM proteins BamA and
BamD.89 TolC has recently been suggested to confound a
new class of BAM substrates. This class of atypical multi-
meric proteins is characterized as being assembled inde-
pendently of non-essential BAM proteins and
periplasmic chaperones, but being strongly affected by a
limitation of the number of functional BAM complexes.
Like the ß-barrel of TolC,90 the ß-barrel of YadA is made
of three identical subunits, each contributing four
ß-strands to build a 12-stranded ß-barrel91 and its multi-
meric ß-barrel is structurally related to TolC. Moreover,
YadA is hardly affected by knockouts of the non-essen-
tial Bam proteins and the periplasmic chaperones but its
assembly is strongly affected even at very early time
points of BamA depletion.70 These criteria support the
idea that YadA might belong to the class of TolC like
BAM substrates. Consequently, we would like to support
the recent suggestion that the susceptibility of these mul-
timeric proteins speciﬁcally to BAM limitations is caused
by the requirement of several BAM complexes to insert a
multimer into the OM.89
We also observed that not only the level of Inv (12
ß-strands) but also the levels of a variety of other
OMPs, FyuA (22 ß-strands), LptD (26 ß-strands),
OmpC (16 ß-strands), OmpF (16 ß-strands) and
LamB (18 ß-strands), were reduced when BamB was
absent. In the case of OmpF and LamB this can at
least partly be attributed to a downregulation at
mRNA level as a result of a sE stress response.92,93,94
Interestingly, we did not observe a markedly reduction
of OmpA and OmpX in the DbamB mutant strain.
The ß-barrels of these OMPs are made of 8 ß-strands,
whereas the ß-barrels of OMPs that show high depen-
dency on BamB for proper insertion, are made of 12
to 26 ß-strands. It was hypothesized previously, that
BamB is more important for the biogenesis of OMPs
that have large ß-barrels by providing an increased
ß-strand binding capacity to the BAM.95 BamB forms
an eight bladed ß-propeller and is suggested to
enhance OMP biogenesis efﬁciency by interacting
with ß-strands from the nascent OMPs through
ß-augmentation before delivering them to
BamA.23,95,96 Our results are in line with observations
suggesting that BamB is important for assembly and
insertion of OMPs consisting of monomeric ß-barrels
with a large number of ß-strands.95 Interestingly, we
found that the OMPs that showed a high dependency
on BamB for proper insertion (Inv, FyuA, LptD)
appeared to be also more dependent on SurA, suggest-
ing that OMPs delivered by SurA preferentially made
use of BamB for assembly. Palomino and coworkers
observed comparable results for the ﬁmbrial usher
FimD, an OMP from E. coli.95 Interestingly, BamA
was kind of an exception from this rule. Although its
b-barrel is composed of 16 b-strands, its abundance
was not reduced in the BamB deﬁcient strain. Given
the central function of BamA for bacterial viability,
we think that it makes sense that it owns some unique
features that render it more independent in how it is
being inserted into the OM. Indeed, it has been shown
previously that in contrast to other OMPs bearing
many ß-strands, BamA is inserted efﬁciently by a
BamACDE complex independently of BamB.97 Thus,
BamA might have structural features which facilitate
its own assembly and render it less reliant on preas-
sembled Bam-complexes compared to other OMPS.
Additionally, we have calculated the grand averages of
protein hydropathy (GRAVY) of all proteins (Fig 3).
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Actually, there is quite a good correlation for the
impact of the absence of BamB on the number of
ß-strands and the hydropathy. The lower the hydropa-
thy, the more striking the reduction of OM protein
levels. Exceptions from this rule are FyuA which has
hydropathy of ¡0,42 albeit consisting of 22 strands
and BamA which is rather unaffected by the absence
of BamB and SurA although having 16 ß-strands and
a GRAVY index of ¡0,40.
Finally, we would like to state that both BamB and SurA
seem to be targets worthwhile to be addressed in future stud-
ies, possibly leading to the development of antivirulence or
sensitizer drugs that will provide then new options to treat
infections caused by Gram-negative bacteria.
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